Research
Cost-effectiveness of screening for hepatitis C in Canada
William W.L. Wong, Hong-Anh Tu, Jordan J. Feld, Tom Wong and Murray Krahn
CMAJ February 17, 2015 187 (3) E110-E121; DOI: https://doi.org/10.1503/cmaj.140711
William W.L. Wong
Toronto Health Economics and Technology Assessment Collaborative, Leslie Dan Faculty of Pharmacy (W. Wong, Krahn), and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto, Toronto, Ont.; Toronto Centre for Liver Disease, University Health Network (Feld), Toronto, Ont.; Public Health Agency of Canada (T. Wong), Ottawa, Ont.
PhDHong-Anh Tu
Toronto Health Economics and Technology Assessment Collaborative, Leslie Dan Faculty of Pharmacy (W. Wong, Krahn), and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto, Toronto, Ont.; Toronto Centre for Liver Disease, University Health Network (Feld), Toronto, Ont.; Public Health Agency of Canada (T. Wong), Ottawa, Ont.
PhDJordan J. Feld
Toronto Health Economics and Technology Assessment Collaborative, Leslie Dan Faculty of Pharmacy (W. Wong, Krahn), and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto, Toronto, Ont.; Toronto Centre for Liver Disease, University Health Network (Feld), Toronto, Ont.; Public Health Agency of Canada (T. Wong), Ottawa, Ont.
MD MPHTom Wong
Toronto Health Economics and Technology Assessment Collaborative, Leslie Dan Faculty of Pharmacy (W. Wong, Krahn), and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto, Toronto, Ont.; Toronto Centre for Liver Disease, University Health Network (Feld), Toronto, Ont.; Public Health Agency of Canada (T. Wong), Ottawa, Ont.
MD MPHMurray Krahn
Toronto Health Economics and Technology Assessment Collaborative, Leslie Dan Faculty of Pharmacy (W. Wong, Krahn), and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto, Toronto, Ont.; Toronto Centre for Liver Disease, University Health Network (Feld), Toronto, Ont.; Public Health Agency of Canada (T. Wong), Ottawa, Ont.
MD MSc
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Cost-effectiveness of screening for hepatitis C in Canada
William W.L. Wong, Hong-Anh Tu, Jordan J. Feld, Tom Wong, Murray Krahn
CMAJ Feb 2015, 187 (3) E110-E121; DOI: 10.1503/cmaj.140711
Jump to section
Related Articles
Cited By...
- Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study
- Cost-effectiveness of telemonitoring screening for diabetic foot ulcer: a mathematical model
- Expanding treatment for hepatitis C in Canada
- The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver
- Model-based projection of health and economic effects of screening for hepatitis C in Canada
- Hepatitis C testing in Canada: dont leave baby boomers behind
- Identifying those infected with hepatitis C virus
- Recommendations on hepatitis C screening for adults
- Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations
- Hospital stays for hepatitis B or C virus infection or primary liver cancer among immigrants: a census-linked population-based cohort study